Showing results (171-180 of 442) with videos related to

Sort By:
Pageof 45
Pharmacoepidemiology and Drug Safety|January 6, 2026
Occurrence of Potential Prescribing Cascades After Hospital Discharge: A Cohort StudyAtiya K Mohammad, Johanna H M Driessen, Jacqueline G Hugtenburg, et al.
Drugs & Aging|October 20, 2023
Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic ReviewOriane Adrien, Atiya K Mohammad, Jacqueline G Hugtenburg, et al.
Physical Review Letters|March 28, 2015
Approaching truly freestanding graphene: the structure of hydrogen-intercalated graphene on 6H-SiC(0001)J Sforzini, L Nemec, T Denig, et al.
British Journal of Clinical Pharmacology|December 4, 2014
Understanding drug preferences, different perspectivesPeter G M Mol, Arna H Arnardottir, Sabine M J Straus, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 30, 2021
Impact of prompt gamma emission of <sup>44</sup>Sc on quantification in preclinical and clinical PET systemsFlorian Rosar, Hendrik Bohnenberger, Euy Sung Moon, et al.
BMC Medical Research Methodology|January 11, 2024
Prescription Sequence Symmetry Analysis (PSSA) to assess prescribing cascades: a step-by-step guideMandy R S Hendrix, Mustafa Yasar, Atiya K Mohammad, et al.
Drug Safety|September 20, 2013
Post-approval safety issues with innovative drugs: a European cohort studyPeter G M Mol, Arna H Arnardottir, Domenico Motola, et al.
Cancers|July 2, 2021
Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort StudyJing de Haan-Du, Gijs W D Landman, Nanne Kleefstra, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 23, 2019
Long-Term Exposure to Anticholinergic and Sedative Medications and Cognitive and Physical Function in Later LifeHans Wouters, Sarah N Hilmer, Danijela Gnjidic, et al.
Diabetologia|December 10, 2024
Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trialsSieta T de Vries, Michelle J Pena, Sok Cin Tye, et al.
Pageof 45